KIT mutations within the activation loop (A-loop), including the amino acids C809, D816, D820, N822, Y823 and A829, have been reported to confer preclinical and clinical resistance to imatinib and sunitinib in GIST [48,58,59]. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.